Highlights
- 1
- 2
- 3
Publications
54 publications
Funding
6 grantsView NIH portfolio on RePORTER ↗
Active
5 grants- Co-ILLS 7027-23Targeting Unmet Needs For B-cell LymphomasLeukemia & Lymphoma Society · 2022–2027
- Co-IP01CA265768-01Investigating cell-intrinsic and extrinsic interactions in prostate cancer at the single cell level ("Core A: Pathobiology")National Cancer Institute · 2022–2027 · via Columbia University
- Co-IW81XWH-19-1-0141Converting HR+ Breast Cancer Into an Individualized VaccineU.S. Department of Defense · 2019–2026
- Co-IW81XWH-21-2-0034Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectoryU.S. Department of Defense · 2021–2026
- KPP01CA272295-02Epigenetic basis and therapeutic targeting of the unique lymphoma immunological nicheNational Cancer Institute · 2024–2026
Completed grants (1)
- KPUM1CA121947-18The AIDS Malignancy Consortium Grant (AMC) - Resource LabNational Cancer Institute · 2020–2025 · via EMMES Corporation
News mentions
4 mentionsView all WCM news ↗
- Mapping Human Bone Marrow Yields New Tool, Insights on Blood CancerJuly 20, 2026
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.
- Awards & Honors: SeptemberSeptember 30, 2024
Awards, honors and achievements for the month of September.
- NIH Grant Will Support Lymphoma ResearchAugust 15, 2024
Weill Cornell Medicine has received a five-year, $12.4 million grant from the National Cancer Institute, part of the National Institutes of Health, for an extensive program of basic and translational research on the biology of diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma.
- Researchers Chart the Contents of Human Bone MarrowNovember 14, 2023
A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow.